Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse.
about
Inflammatory breast cancer: New factors contribute to disease etiology: A reviewAndrogen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitorsRelationship between morphological features and kinetic patterns of enhancement of the dynamic breast magnetic resonance imaging and clinico-pathological and biological factors in invasive breast cancer.Study of matrix metalloproteinases and their inhibitors in prostate cancer.Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasisTIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group.Serum endostatin levels are elevated in colorectal cancer and correlate with invasion and systemic inflammatory markers.Relationship between the inflammatory molecular profile of breast carcinomas and distant metastasis development.Impact of CD68/(CD3+CD20) ratio at the invasive front of primary tumors on distant metastasis development in breast cancerCancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13.Near-infrared triple-helical peptide with quenched fluorophores for optical imaging of MMP-2 and MMP-9 proteolytic activity in vivo.Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma.Microarray and proteomic analysis of breast cancer cell and osteoblast co-cultures: role of osteoblast matrix metalloproteinase (MMP)-13 in bone metastasis.Role of traditional and new biomarkers in breast carcinogenesis.Membrane type-1 matrix metalloproteinase (MT1-MMP) correlates with the expression and activation of matrix metalloproteinase-2 (MMP-2) in inflammatory breast cancerA phenotype from tumor stroma based on the expression of metalloproteases and their inhibitors, associated with prognosis in breast cancer.Matrix metalloproteinases as breast cancer drivers and therapeutic targets.TIMP-2 targets tumor-associated myeloid suppressor cells with effects in cancer immune dysfunction and angiogenesisInflammation and breast cancer: metalloproteinases as common effectors of inflammation and extracellular matrix breakdown in breast cancerDetection of prognostic factors in metastatic breast cancer.Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties.Evaluation of a triple-helical peptide with quenched FluorSophores for optical imaging of MMP-2 and MMP-9 proteolytic activity.Cytokines related to MMP-11 expression by inflammatory cells and breast cancer metastasis.Inflammation and cancer.Immunohistochemical expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in invasive breast carcinomaPlasma levels of matrix metalloproteinases 2 and 9 correlate with histological grade in breast cancer patientsTherapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer.Comparative study of the expression of metalloproteases and their inhibitors in different localizations within primary tumours and in metastatic lymph nodes of breast cancer.
P2860
Q27027856-2ED84F73-D317-48C0-9379-82B75ED2822FQ33338236-340AFB06-85B9-43D3-A562-EE83B2D78024Q33523150-B2778D8D-272E-4E1F-8FFD-54404EE751F8Q33708162-A8327277-07D3-42E4-BB70-B473BE6CEF12Q33762632-FA39D86C-1EA5-4AA6-9B42-87244E9CEF97Q33880656-3F139DFD-C0AB-415E-8C87-98DD6951261BQ34354606-90D096C1-78EA-4212-AAD2-AD2322B524FEQ34473935-2ED41C72-74B1-4235-80B6-9E1A6231113BQ34541239-44CD7567-913F-4674-9EDC-3E441F519B89Q35008756-25622D16-1199-46FC-8A5C-DA2D413F71F0Q35114441-5AE19318-AEFD-4D9F-8B81-6826FDE58498Q35235996-6DCFFBE0-C83A-4D61-9784-BB184DE8EC24Q35310572-82E38209-7750-4D79-A5BF-EAA8E76EF690Q35572905-95AB3174-56B5-4146-AFAC-066A7722AEFCQ35586223-46CC6AAD-5482-439B-B971-4E00A1DA9979Q35798885-7B78A9BA-6B05-486A-A2E8-E397814777D8Q35892721-AD658C19-F13D-4505-A0D0-5AB02184590BQ36108579-DC84537D-3A13-407D-931A-CF05F023DE56Q36678647-4CB912D4-85DA-4BAE-9527-4BA06BD2EC90Q37222128-DC26891D-7C68-4E05-A845-3C5EF7C7E73AQ37592080-B3886A72-0D62-429E-B693-327A0D403EF1Q38981765-5EF5AD37-B90E-439D-B8C8-0793C76E8E32Q41219034-9A213B01-1C17-4480-80DD-CC260328142EQ41853728-389C434D-4639-48DD-8E52-65587C693E06Q42375660-B238DBD5-7B92-4A0F-AA12-55BE269B889DQ42416955-CB82C3CA-B9C2-43D5-B44C-484929D5C791Q42720277-179E4C29-54CC-42AD-B755-18EDAC1DB5EAQ44131334-C99328FE-F38B-4E12-A099-2D43DE13747B
P2860
Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Overexpression of matrix metal ...... lates with metastasis-relapse.
@ast
Overexpression of matrix metal ...... lates with metastasis-relapse.
@en
type
label
Overexpression of matrix metal ...... lates with metastasis-relapse.
@ast
Overexpression of matrix metal ...... lates with metastasis-relapse.
@en
prefLabel
Overexpression of matrix metal ...... lates with metastasis-relapse.
@ast
Overexpression of matrix metal ...... lates with metastasis-relapse.
@en
P2093
P2860
P356
P1476
Overexpression of matrix metal ...... lates with metastasis-relapse.
@en
P2093
A M Merino
F J Vizoso
J C Rodríguez
J L García-Muñiz
L O González
M L Lamelas
S Junquera
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603963
P407
P577
2007-09-11T00:00:00Z